Diamond Hill Capital Comments on Boston Scientific Corp

Author's Avatar
Oct 17, 2014

Shares of Boston Scientific Corp. (BSX) declined as investors focused on potential liabilities stemming from legal disputes. We continue to see improvement in revenue trends and believe they will be key factors in closing the discount to our estimate of intrinsic value over time.

From Diamond Hill Capital (Trades, Portfolio)'s Select Fund Third Quarter 2014 Commentary.